Pevonedistat
| Price | $1 |
| Package | 1g |
| Min. Order: | 1g |
| Supply Ability: | 20tons |
| Update Time: | 2024-10-22 |
Product Details
| Product Name: Pevonedistat | CAS No.: 905579-51-3 |
| Min. Order: 1g | Purity: 85.0-99.8% |
| Supply Ability: 20tons | Release date: 2024/10/22 |
| NO: Pevonedistat |
| Product Name: | Pevonedistat |
| Synonyms: | ((1S,2S,4R)-4-(4-(((S)-2,3-dihydro-1H-inden-1-yl)aMino)-7H-pyrrolo[2,3-d]pyriMidin-7-yl)-2-hydroxycyclopentyl)Methyl sulfaMate;[(1S,2S,4R)-4-(4-{[(1S)-2,3-dihydro-1H-inden-1-yl]aMino}-7H-pyrrolo[2,3-d]pyriMidin-7-yl)-2-hydroxycyclopentyl]Methyl sulfaMate;CS-821;TAK-924;PEVONEDISTAT;MLN-4924;Pevonedistat;MLN4924 (Pevonedistat);Sulfamic acid [(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]-7H-pyrrolo[2,3-d]pyrimi |
| CAS: | 905579-51-3 |
| MF: | C21H25N5O4S |
| MW: | 443.5193 |
| EINECS: | |
| Product Categories: | Bases & Related Reagents;Carbohydrates & Derivatives;Heterocycles;Inhibitors;Intermediates & Fine Chemicals;Nucleotides;Pharmaceuticals |
| Mol File: | 905579-51-3.mol |
Company Profile Introduction
Technology research and transfer of pilot screening, pilot scale-up and mass production solutions , for pharmaceutical intermediates, biologicals and fine chemicals (Not including inflammable , explosive , hazardous goods ) ; Market : Nano material , metal catalyst , raw material of cosmetics , pharmaceutical intermediates , chemicals , photoelectric material , import and export of technology and goods (For projects subject to approval according to law, business activities can be carried out only after approval by relevant departments ).
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $48.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-05-12 | |
| $1.10 |
VIP6Y
|
Dideu Industries Group Limited
|
2025-11-18 | |
|
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2020-02-26 |
China- Since: 2020-12-17
- Address: Room 702, Floor 7, Building 10, National University Science Park, High-Tech Zone, Zhengzhou City, He
INQUIRY